ArticleFrontiers in genetics2026
The association between the
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are associated with increased risk of osteoporosis. Beyond established environmental factors, genetic determinants and the impact of lactose intolerance on calcium-phosphate balance and bone mineralization are increasingly considered. The aim of this study was to evaluate the association between the LCT-13910C>T (rs4988235) polymorphism in the Methods: A total of 125 patients (50 with UC, 75 with CD) and 39 healthy controls were enrolled. Genotyping was performed by high-resolution melting (HRM) analysis with Sanger sequencing confirmation for selected samples. BMD was measured at L1-L4 and at the femoral neck; selected biochemical parameters were also assessed. Results: Patients with IBD exhibited lower BMD compared with controls. Analysis of rs4988235 distribution revealed no statistically significant differences between patients and controls, although a higher frequency of the C allele and CC genotype was observed among patients. Genotype-phenotype analyses showed no significant associations for most parameters; the sole exception was the femoral neck in the CD subgroup, where CT heterozygotes had higher BMD than CC homozygotes. Conclusion: The LCT-13910C>T polymorphism does not appear to be independently associated with BMD in patients with IBD in this cohort. Given the moderate sample size and lack of adjustment for key confounders, the findings should be considered exploratory and require confirmation in larger, well-controlled studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.